Strong Fundamentals in Biotech Justify Even Higher Valuation Levels
December 11, 2014
Cancer Immunotherapy a Top Focus in Biotechnology Sector
August 20, 2014
Opportunities in Hepatitis C and Genomic Technologies
April 08, 2013
U.S. Biotech Valuations Appear Attractive Despite Earlier Run
August 17, 2012
L.FRIDAY / P.SWANSON - KING INVESTMENT ADVISORS INC
November 14, 2005
LARGE & MID-CAP BIOTECHNOLOGY COMPANIES: LEI ZHONG - RODMAN & RENSHAW
May 03, 2004
Investment Opportunities In The Energy Supply Chain: J.smith - Gabelli Asset Management
September 01, 2003
Russel Medford - Atherogenics Inc (agix)
October 12, 2001
David Main - Inex Pharmaceutical Corporation (iex.to)
October 01, 2001
Anthony Armini - Implant Sciences Corporation (imx)
May 29, 2000
